Dismenol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dismenol

Quick Facts

Property Description
Active ingredient Ibuprofen
Form Film-coated tablet
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General purpose Relief of pain, inflammation, and fever
Origin Synthetic chemical compound

Dismenol is a widely recognized pharmaceutical product used for the general self-management of pain, fever, and inflammation. The medicine is built around the core active ingredient, Ibuprofen, which is officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Primarily marketed in European countries, Dismenol is commonly available Over-The-Counter (OTC) for adult and adolescent use.


What Type of Medicine is Dismenol?

Dismenol is a medicine belonging to the Nonsteroidal Anti-Inflammatory Drug (NSAID) pharmacological class. The active substance, Ibuprofen, is a synthetic chemical compound derived from propionic acid, distinguishing its chemical structure from natural remedies. The NSAID class is defined by its mechanism of action: inhibiting the activity of cyclooxygenase (COX) enzymes, which are responsible for initiating the body's inflammatory and pain pathways. This inhibition is an established mechanism for therapeutic action.


Composition and Physical Form of Dismenol

The most common presentation of Dismenol is a single-active ingredient product delivered as a film-coated tablet intended for oral administration. The brand is often known for its easily ingestible tablet form. This solid oral dosage form ensures a precise, measured dose of Ibuprofen is delivered into the digestive system for systemic absorption, meaning the active substance acts throughout the body. Film-coatings on tablets are typically applied to stabilize the active ingredient and improve patient compliance by making the tablet easier to swallow.


Dismenol’s General Purpose: The Triple Effect

  • The general purpose of Dismenol is to provide comprehensive symptomatic relief through its inherent triple physiological effects: it is reliably analgesic (pain relief), effectively antipyretic (fever lowering), and demonstrably anti-inflammatory (inflammation reduction). For example, Dismenol is often used for the temporary relief of general body discomfort that may accompany common minor irritations. The ability to address these three physiological consequences simultaneously is the core reason for the broad utility of NSAIDs like Dismenol in managing common discomforts.

Regulatory References

  1. Ibuprofen: MedlinePlus Drug Information
  2. Ibuprofen on the WHO Essential Medicines List

What side effects are possible with Dismenol?

Possible side effects and safety information

Official regulatory information addresses side effects and safety concerns, classifying adverse reactions by the affected body system and frequency. Serious risks are explicitly associated with dose level and treatment duration.


Adverse Reaction Scope

Key Organ Systems Involved: Reactions are formally documented across several System-Organ Classes, including Gastrointestinal, Nervous System, Skin and Subcutaneous Tissue, Blood and Lymphatic System, Cardiac, and Vascular disorders. Gastrointestinal issues and headache are among the most frequently reported adverse effects.

Serious Adverse Reactions: Life-threatening events reported in official documents include gastrointestinal bleeding, ulceration, or perforation, which can occur without warning. Serious cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke, have also been associated with this class of medicine.


Safety Restrictions and Limitations

Dose- and Duration-Related Patterns: The risk of serious reactions, including gastrointestinal complications and cardiovascular thrombotic events, is explicitly stated to increase with higher dosage levels and longer duration of use. Therefore, the official safety framework requires using the lowest effective dose for the shortest possible duration.

Population-Specific Considerations: Use must be avoided during the third trimester of pregnancy due to risk of fetal harm (cardiopulmonary and renal toxicity). Additionally, like other medicines in its class, it may temporarily impair female fertility.

Immediate Actions Required: Treatment must be stopped immediately if signs of serious skin reactions (e.g., severe rash, blistering), severe allergic reactions, or signs of gastrointestinal bleeding (e.g., bloody or black stools, vomiting blood) occur.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Dismenol (Ibuprofen) overdose outlines specific manifestations and strictly mandated emergency actions based on potential for serious outcomes.

Domain Officially Documented Overdose Information
Documented Manifestations Symptoms may include gastrointestinal effects (e.g., nausea, vomiting, abdominal pain, diarrhea) and Central Nervous System disturbances (e.g., headache, dizziness, drowsiness, tinnitus, coma, nystagmus). Metabolic acidosis is a documented physiological finding.
Severe Systemic Risks Overdose carries the potential for severe and life-threatening outcomes, including acute renal failure, hepatic dysfunction, hypotension (low blood pressure), and, rarely, cardiac arrest.
Required Emergency Action Regulators mandate that individuals seek immediate medical attention by contacting emergency services or a poison control center in all suspected overdose situations, even if initially asymptomatic.

Official Overdose Statements

  • The management of overdose is exclusively symptomatic and supportive, as official documentation confirms that no specific antidote is known for Ibuprofen.
  • In the professional setting, procedures such as gastric lavage or administration of activated charcoal may be considered shortly after ingestion to limit absorption.
  • Hospital monitoring for several hours is required to observe for the potential delayed onset of severe CNS, renal, and hepatic effects, particularly following massive exposure.

Therapeutic Uses of Dismenol

What Dismenol Treats: Main Uses and Benefits

Dismenol is applied in contexts where short-term symptomatic assistance is needed for symptom management, helping to address symptom clusters that may become intense or disruptive. The active ingredient, Ibuprofen, is relevant in situations involving heightened systemic burden. It is commonly used when supportive symptom management is appropriate, contributing to improved comfort during periods of heightened symptoms.


Symptomatic Relief for Acute Discomfort

The medication is relevant for managing symptoms related to physical discomfort, commonly used across conditions characterized by episodic or fluctuating manifestations. These conditions include headache, toothache, generalized body aches, and the cyclical discomfort of primary dysmenorrhea (menstrual cramps). Dismenol is also applied during phases when symptoms become more noticeable related to seasonal illnesses like the cold or flu, and plays a role in managing fever (pyrexia). This therapeutic approach is used for managing symptoms and contributes to improved comfort during symptomatic periods.

“Dismenol supports patients during episodes of heightened discomfort where pain and fever become more noticeable.”

It is relevant in situations involving symptoms related to inflammatory or irritative states, targeting swelling, tenderness, and stiffness associated with minor soft-tissue injury or arthritis pain. This use contributes to easing the overall symptom load.


Quick Fact: Relief for Acute Discomfort
Primary Domain Focus Pain, Fever, and Inflammation symptoms
Typical Severity Targeted Mild to moderate pain; acute symptoms
Benefit to Patient Supports the patient by easing the overall symptom load

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Dismenol's eligibility profile is based on regulatory standards for its active ingredient, Ibuprofen. Eligibility is strictly defined by patient history, organ function, and specific physiological states, as documented in governmental labeling.

Absolute Contraindications (Must Not Use)

Classification Examples of Ineligible Groups/Conditions
Hypersensitivity Known allergy to Ibuprofen, Aspirin, or other NSAIDs.
Organ/GI Failure Severe heart failure, severe hepatic or renal failure, active or recurrent peptic ulcer/hemorrhage.
Physiological State Third trimester of pregnancy, post-coronary artery bypass graft (CABG) surgery.

Restricted or Conditional Use (Use with Caution)

Individuals in these groups are typically eligible but require medical supervision or use of the lowest effective dose for the shortest duration, as defined by official regulatory bodies:

  • Elderly Patients (Increased risk of severe adverse effects).
  • Patients with mild/moderate renal or hepatic impairment (Function must be monitored).
  • Pregnancy (First/Second Trimester) (Use only if clearly necessary and indicated).

Children under six years of age or below 20 kg body weight are generally contraindicated for most oral formulations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated and Restricted Combinations

The regulatory profile for Dismenol (Ibuprofen) mandates strict restrictions on co-administration with specific drug classes. The use of other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, is prohibited due to the formally documented additive risk of serious gastrointestinal bleeding and ulceration. Use is also contraindicated for the management of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Furthermore, taking alcohol is documented to increase the risk of gastrointestinal bleeding.


Pharmacokinetic and Pharmacodynamic Interactions

Ibuprofen may cause a pharmacokinetic interaction by reducing the renal elimination of certain medicines, leading to increased plasma concentrations and toxicity risk for substances such as Lithium and Methotrexate. A key administration-timing rule is required for low-dose, immediate-release (IR) Aspirin: Ibuprofen must be administered at least eight hours before or thirty minutes after the aspirin dose to prevent interference with its anti-platelet effect.

Pharmacodynamically, co-administration with Anticoagulants (e.g., Warfarin), Oral Corticosteroids, or SSRIs is documented to increase the overall risk of bleeding. Ibuprofen may also officially reduce the anti-hypertensive or diuretic effect of blood pressure medicines, including ACE inhibitors and Diuretics.

Mechanism of Action

How Dismenol Works — Mechanism of Action

The mechanism of Dismenol (Ibuprofen) is defined by its ability to modulate the body's signaling pathways by inhibiting a group of enzymes central to the synthesis of pro-inflammatory mediators and the regulation of core body temperature.


Key Pathway: Molecular Blockade of COX Enzymes

Dismenol exerts its primary biological action by acting as a reversible inhibitor of both Cyclooxygenase-1 ( COX-1) and Cyclooxygenase-2 ( COX-2) enzymes. By blocking the active site of these enzymes, the drug prevents the conversion of Arachidonic Acid into key signaling molecules, predominantly prostaglandins and thromboxanes. This fundamental step shapes all of the drug's physiological consequences.


Mechanism 1: Peripheral Pain Signal Dampening

The core mechanism of enzyme inhibition reduces the synthesis of Prostaglandin E2 ( PGE2) in peripheral tissues. Lower PGE2 levels directly reduce the sensitivity of peripheral pain nerve endings ( nociceptors) to local chemical stimuli, physiologically raising the pain threshold at the site of tissue stress and decreasing prostaglandin-mediated vasodilation and vascular permeability.


Mechanism 2: Central Thermoregulatory Resetting

A portion of the active ingredient enters the Central Nervous System ( CNS) to act specifically on the hypothalamus, the brain's temperature-control center. Here, the drug blocks the prostaglandin signaling that causes the central thermal set-point to rise, leading to a physiological resetting that enhances heat loss mechanisms.

Dosage and Administration Information

How to Use Dismenol

Dismenol (Ibuprofen) is an oral Nonsteroidal Anti-Inflammatory Drug (NSAID) whose administration is governed by established use guidelines. The core principle of its use is to administer the lowest effective dose for the shortest duration necessary to manage symptoms.


Official Administration Protocol

The primary approved route of administration for Dismenol tablets is oral.

Category Official Instruction
Route of Administration Oral (Swallowed)
Common Strengths 200 mg or 400 mg (Ibuprofen)

Standard Dosing and Frequency

Official dosing is structured around standard adult requirements for short-term symptomatic relief:

  • Standard Oral Dose: The usual dose is 200 mg to 400 mg.
  • Dosing Frequency: Doses are typically repeated every 4 to 6 hours as required for symptom control.
  • Maximum Daily Dose (OTC): Use must not exceed 1,200 mg in a 24-hour period for non-prescription use.

Administration Requirements and Duration

Specific instructions ensure proper intake and safe use duration:

  • Method of Intake: The film-coated tablet must be swallowed whole with water. Instructions specifically advise against crushing, chewing, or breaking the tablet.
  • Contextual Intake: Taking the tablet with food or milk is often recommended to reduce the potential for stomach upset.
  • Duration Constraint: For self-management of pain or fever, the use of Dismenol should generally not exceed 10 days for pain or 3 days for fever unless directed by a healthcare provider.

Recent Clinical Evidence

Research evidence / Overview of studies for Dismenol

The information below summarizes the types of research and clinical trials that have explored the active ingredient in Dismenol, Ibuprofen, according to authoritative scientific and regulatory sources. This overview is intended to provide context on the available evidence without offering clinical guidance or predicting individual results.


Evidence for Use in Acute Pain

The research base for used in research exploring how symptoms change over time for outcomes related to physical discomfort (such as mild to moderate acute pain) relies heavily on short-term Randomized Controlled Trials (RCTs) and large Systematic Reviews.

Findings describe patterns observed in the studies where Ibuprofen was evaluated against placebo or other agents. Research highlights changes measured during the study period across diverse acute pain models. The available evidence for acute pain management is characterized by its short-term focus. Data are still emerging, and long-term effects are not fully established when tracking symptom patterns for periods exceeding a few days.


Evidence for Use in Primary Dysmenorrhea

Ibuprofen was studied for conditions characterized by fluctuating or episodic manifestations, specifically primary dysmenorrhea (menstrual pain). The research exploring short-term symptom changes in this area relies on RCTs that often compared Ibuprofen to a placebo or other agents. Studies monitored outcomes related to physical discomfort, such as changes in pain intensity. There is limited information for long-term outcomes related to the sustained use of Ibuprofen over many years. Comparative evidence is lacking against certain newer non-opioid agents.


Evidence for Antipyretic Use (Fever Reduction)

Research examined outcomes related to systemic or functional imbalance, specifically fever. The evidence is derived from multiple RCTs and Meta-analyses that compared the treatment against placebo and against other established fever-reducing agents. Research highlights changes measured during the study period; changes in body temperature were observed in the study populations. Evidence quality varies across studies regarding the study of alternating Ibuprofen with other fever-reducing agents. Results apply only to the populations studied.


Evidence in Special Populations

Research focused on special populations has included dedicated studies on specific groups, such as children (aged 6 months and older). Research focused on these younger populations was evaluated for outcomes related to physical discomfort and outcomes monitoring physiological strain or stress. Evidence is limited regarding specific outcomes for older adults with multiple, complex comorbidities.

Key Studies & References World Health Organization (WHO) Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Dismenol (FAQ)

Q: What is the difference between Dismenol and a standard pain reliever like ibuprofen?

Dismenol is a brand name medication, while Ibuprofen is the globally recognized generic name for the active substance. The official product information confirms that Ibuprofen is the sole active ingredient in Dismenol.

Q: Is Dismenol a brand name or a generic name?

Dismenol is a brand name product. Its active component, Ibuprofen, is the internationally recognized generic name.

Q: Is there a generic version of Dismenol available?

The active ingredient in Dismenol, Ibuprofen, is widely available globally as a non-branded generic medicine.

Q: Is the active ingredient in Dismenol used in other common medications?

The active ingredient, Ibuprofen, is included on the World Health Organization's Model List of Essential Medicines. Regulatory sources confirm it is a widely used substance in many different brand-name products internationally.

Q: Does Dismenol contain aspirin?

No. The composition listed in official regulatory documents confirms that the only active ingredient in Dismenol is Ibuprofen. The product does not contain aspirin.

Q: How quickly does Dismenol usually start to work?

Regulatory pharmacokinetic data is available, which indicates the time the drug takes to reach its maximum concentration in the blood. This data provides insight into the drug's absorption, which can be used to estimate when effects may begin.

Q: How long does the effect of Dismenol typically last?

Official dosing guidelines state that repeat doses are typically administered every 4 to 6 hours as required for symptom control. This interval reflects the typical duration of the analgesic (pain-relieving) and antipyretic (fever-reducing) effects.

Q: Can Dismenol be taken before the pain starts?

Regulatory guidelines indicate that the drug is to be taken 'as required for symptom control' or for 'short-term symptomatic relief.' This implies use at or shortly after the onset of symptoms or pain.

Q: Are there specific times of the month Dismenol is recommended to be used?

The medicine is officially approved for use during the onset of symptoms. This includes the pain associated with primary dysmenorrhea (menstrual pain), and should be taken as needed.

Q: What happens if I forget to take Dismenol and the pain gets bad?

Official patient information often describes how to manage a missed dose. Guidance is typically to take the dose as soon as it is remembered, while ensuring the recommended time interval is respected before the next scheduled dose.

Q: How long can I continue taking Dismenol for menstrual pain?

For the self-management of pain, the duration of use should generally not exceed 10 days unless a healthcare provider directs otherwise.

Q: Can Dismenol be taken on an empty stomach?

Official regulatory documents frequently advise taking the medicine with food or milk to help minimize the potential for stomach upset. While use on an empty stomach is not strictly prohibited, taking it with food is a common precaution noted in patient guidance.

Q: Is Dismenol a prescription drug or is it available over-the-counter?

The medicine is commonly available Over-The-Counter (OTC) for its lower strengths. However, higher dose strengths of the active ingredient may be restricted to prescription use depending on the regulatory rules in different regions.

Q: Can men take Dismenol for pain relief?

The medicine's approved uses, which include relief of general pain, inflammation, and fever, are based on physiological effects. Official indications for these uses apply equally to both men and women.

Q: Can teenagers use Dismenol for period pain?

The medicine is typically approved for use by adolescents (teenagers) and adults, provided the user meets the specified age and minimum weight criteria listed on the regulatory label.

Q: Is Dismenol generally safe for older women to use?

Official documents note that elderly patients are classified as having an increased risk of severe adverse effects. Due to this risk, the regulatory safety framework requires using the lowest effective dose for the shortest possible duration.

Q: Can taking Dismenol upset my stomach?

Official documents confirm that Gastrointestinal issues, such as indigestion or stomach upset, are among the frequently reported adverse effects. Taking the tablet with food or milk is frequently advised in patient guidance to help mitigate this risk.

Q: Does Dismenol cause drowsiness or make you tired?

Regulatory labels list adverse reactions that affect the central nervous system (CNS). These can include symptoms such as somnolence (drowsiness) or fatigue, although they may not be classified as common side effects.

Q: Why might someone feel dizzy after taking Dismenol?

Dizziness is documented in clinical experience as an adverse reaction, often classified as a nervous system effect. Official documents typically instruct patients to seek guidance from a healthcare professional if this or any other adverse effect is persistent or severe.

Q: Can Dismenol cause skin reactions or rashes?

Official documents explicitly warn of the risk of serious skin reactions (e.g., severe rash or blistering). Official documents state that treatment should be stopped immediately if signs of such a serious reaction occur.

Q: What should I do if I experience a very rare side effect from Dismenol?

Official patient documents typically instruct individuals to contact a healthcare provider immediately if they experience any side effect, including those not specifically listed. This is to ensure appropriate medical attention and regulatory reporting.

Q: Are there any long-term side effects associated with regular Dismenol use?

Official regulatory warnings state that the risk of serious side effects, including gastrointestinal bleeding and cardiovascular events, is documented to increase with higher dosage levels and longer duration of use.

Q: Is it possible to become dependent on Dismenol?

The active ingredient, Ibuprofen, is not classified as a controlled substance. Official documentation does not indicate a risk of physical dependence or addiction with this medicine.

Q: Do studies suggest Dismenol has a low risk of dependency?

The active ingredient, Ibuprofen, is not classified as a controlled substance and is not associated with dependency risk in official regulatory materials.

Q: Does Dismenol have a known rebound effect if stopped suddenly?

Regulatory documents do not list a known rebound effect, such as medication-overuse headache, associated with the short-term use of this medicine for its labeled indications.

Q: Can Dismenol be taken with other over-the-counter pain medicines?

Regulatory documents strictly prohibit use with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including those available over-the-counter, due to a formally documented risk of increased side effects. Whether it can be combined with non-NSAID relievers is not explicitly detailed in all labels.

Q: Are there any common foods or drinks that should be avoided when taking Dismenol?

The only specific ingestible substance formally documented as a risk is alcohol, which is noted to increase the risk of gastrointestinal bleeding when co-administered. No other common foods or non-alcoholic drinks are formally documented as interactions.

Q: Does Dismenol interact with vitamins or supplements?

Official documents list specific interactions with certain herbal products (e.g., those that may increase bleeding risk). However, general multi-vitamins and standard supplements are not typically listed as clinically significant interactions.

Q: Does Dismenol affect birth control pills?

Official regulatory drug interaction documents generally do not list an interaction between the active ingredient and standard oral hormonal contraceptives (birth control pills).

Q: Does Dismenol affect blood pressure?

Regulatory documents state that the medicine may reduce the blood pressure-lowering effect of certain anti-hypertensive and diuretic medications. This interaction is noted in the official prescribing information.

Q: Is Dismenol safe to take if I have asthma?

Official documents state that the medicine is contraindicated or requires extreme caution in patients with asthma. This is especially true if a patient has previously experienced allergic reactions to aspirin or other NSAIDs.

Q: Does Dismenol have a known cross-sensitivity with other drugs?

Use is absolutely contraindicated in individuals with a known hypersensitivity or allergic reaction to Ibuprofen, Aspirin, or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), indicating a risk across this class of medicine.

Q: Does Dismenol affect fertility?

Official regulatory documents note that the medicine may temporarily impair female fertility. This effect is generally documented as being reversible upon discontinuation of treatment.

Q: Does taking Dismenol affect liver function?

Official documents contain warnings regarding the potential for severe hepatic (liver) failure. Caution is required when used in patients with pre-existing liver impairment, and liver function monitoring may be necessary.

Q: Why do some people say Dismenol didn't work for their cramps?

Regulatory reviews of clinical studies often report variations in patient response to pain medications. This means that, even when used correctly, effectiveness can differ substantially among individuals.

Q: Can Dismenol be used for pain related to conditions like endometriosis (informational question)?

Official indications list the relief of symptoms related to primary dysmenorrhea (menstrual pain) and general pain. The label does not specifically include the relief of pain from underlying conditions such as endometriosis.

Q: What are the key points to discuss with a healthcare provider about Dismenol?

Official labeling contains essential information that should be considered for discussion with a healthcare provider. This includes absolute contraindications (e.g., severe allergy, organ failure), key warnings (like GI bleeding or CV risk), and potential drug interactions.

How should Dismenol be stored and disposed of?

How to Store and Dispose of Dismenol (Ibuprofen)

Official regulatory guidelines for Dismenol tablets emphasize specific storage and disposal requirements to ensure product integrity and public safety.


Storage Conditions

Dismenol must be stored at controlled room temperature, typically 20 mathrmC to 25 mathrmC (68 mathrmF to 77 mathrmF). It is essential to avoid excessive heat above 40 mathrmC (104 mathrmF) and to protect the tablets from moisture and humidity. The medication must be kept in its tight, original container, and the cap must be securely fastened to maintain child resistance.


Child Safety and Disposal

All medicines must be stored out of the sight and reach of children.

For disposal, unused or expired Dismenol should be managed through a drug take-back program. If a take-back option is unavailable, the medicine can be sealed in the household trash after being mixed with an unappealing substance such as used coffee grounds or cat litter. Tablets must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dismenol found in:

A-Z Index: